The largest database of trusted experimental protocols
> Disorders > Neoplastic Process > CD30+ Anaplastic Large Cell Lymphoma

CD30+ Anaplastic Large Cell Lymphoma

CD30+ Anaplastic Large Cell Lymphoma is a rare and aggressive form of non-Hodgkin lymphoma, characterized by the expression of the CD30 antigen on the surface of malignant T cells.
This type of lymphoma is often challenging to manage, requiring a multimodal approach to treatment.
Researchers studying CD30+ Anaplastic Large Cell Lymphoma can leverage the AI-driven platform PubCompare.ai to optimize their research efforts.
PubCompare.ai enables seamless comparisons of protocols from literature, pre-prints, and patents, helping researchers identify the most effective approaches to accelerate breakthroughs in this complex disease.
With its advanced AI capabilities, PubCompare.ai is an invaluable tool for researchers working to improve outcomes for patients with CD30+ Anaplastic Large Cell Lymphoma.

Most cited protocols related to «CD30+ Anaplastic Large Cell Lymphoma»

We performed a retrospective review of baseline characteristics of the patients; these include age, sex, round of surgery (primary and revision breast augmentation), smoking status (never, current, and former smokers), body mass index, the type and volume of breast implant, and the type of surgical approach.
For safety assessment, we analyzed incidences of complications after an implant-based augmentation mammaplasty; potential complications include CC, implant malposition or rippling, breast deformation or asymmetry, wound or skin problems, infection, hematoma or hemorrhage, implant rupture, seroma, abscess, silicone granuloma or implant extrusion, double capsule, folding, upside-down rotation, and breast implant–associated anaplastic large cell lymphoma.23 (link)–31 (link)
Publication 2019
Abscess Breast Breast Prosthesis, Internal Capsule CD30+ Anaplastic Large Cell Lymphoma Granuloma Hematoma Hemorrhage Index, Body Mass Infection Lanugo Mammaplasty Operative Surgical Procedures Patients Safety Seroma Silicones Skin Wounds
Sterile biopsy or fine needle aspirate (FNA) samples were available from 28 dogs (four dogs from cohort-I and 24 dogs in cohort-II) with a diagnosis of B-cell lymphoma at participating veterinary hospitals with owner consent under protocols approved by the University of Minnesota Institutional Animal Care and Use Committee (IACUC) and the Colorado Multiple Institutional Review Board. The 28 dogs were from 14 breeds, including six Golden Retrievers, four Labrador Retrievers, two Pembroke Welsh Corgis, two Standard Poodles, and one each of 10 other breeds, as well as four mixed breed dogs. The gender distribution was 50:50, and the average age was 8.6 years (median = 9 years, range 3 - 14). Normal tissue controls were obtained at the time of euthanasia from six healthy, purpose-bred, one-year-old female Beagle dogs that were part of an unrelated project. Collection of normal tissues was done under a protocol approved by the University of Minnesota IACUC. Sample preparation for histopathology, cytology, and flow cytometry was performed as described.17 (link) The final histopathological classification was determined by one author (VEV) with a consensus of three additional authors (DI, TDO, JFM) upon review of the specimens. Tumors were classified according to the modified WHO classification.18 They included 13 diffuse large B-cell lymphomas, four Burkitt-like lymphomas, two marginal zone lymphomas, two low-grade B-cell lymphomas of intermediate centrocytic cells with cleaved nuclei, one follicular lymphoma, and one anaplastic large cell lymphoma. Sufficient sample material was not available for histopathological analysis of five cases. An uncommon phenotype of canine B-cell lymphomas that express CD34 was previously reported.19 (link) Because it is unclear if this represents a unique subtype with distinct biology, inclusion criteria for samples was set as <5% CD34+ cells in the tumor populations to limit the confounding effects of this variable. NOD/SCID/IL-2Rγ−/− (NSG) mice were purchased from Jackson Laboratories (Bar Harbor, ME) and maintained under specific pathogen-free conditions according to institutional guidelines. Lymph node collection from dogs and xenotransplantation of canine lymphoma cells into conditioned, immunocompromised (NSG) mice were conducted with approval of the University of Minnesota IACUC.
Publication 2011
Aspiration Biopsy, Fine-Needle B-Cell Lymphomas Biopsy Burkitt Lymphoma Canis familiaris CD30+ Anaplastic Large Cell Lymphoma Cell Nucleus Cells Cytological Techniques Diagnosis Diffuse Large B-Cell Lymphoma Ethics Committees, Research Euthanasia Flow Cytometry Institutional Animal Care and Use Committees Lymphoma Lymphoma, Follicular Mucosa-Associated Lymphoid Tissue Lymphoma Mus Neoplasms Nodes, Lymph Phenotype Population Group SCID Mice Specific Pathogen Free Sterility, Reproductive Tissues Woman Xenografting
5536 anonymized tumors, including germ cell, epithelial, mesenchymal, melanocytic/neuroectodermal, and lymphohematopoietic tumors, and normal tissues derived from surgical specimens were assembled to multitumor blocks containing 30 to 70 rectangular tissue samples as previously described. (26 (link)) The size of tumor tissue samples was estimated to exceed the size of a single 0.6mm2 core by a factor of 10–15. All tumors, selected for this study, were extensively characterized histologically and immunohistochemically. In addition, a 10-week-old fetus was immunohistochemically analyzed.
The rabbit monoclonal antibodies clone E1L3N (#13684) and 28-8 (ab205921) against PD-L1 were obtained from Cell Signaling Technology, Inc. (Danvers, MA) and Abcam Inc. (Cambridge, MA) , respectively. The antibodies were applied at a dilution of 1:200 (E1L3N) and 1:500 (28 (link)–8 (link)) to selected normal and tumor tissue arrays. Both of the antibodies showed almost similar staining patterns in placental trophoblast, choriocarcinoma, anaplastic large cell lymphoma (ALCL), and squamous cell carcinoma of lung. However, we selected clone E1L3N because of its lower background signal.
Immunostaining was performed with the Leica Bond-Max automation and Leica Refine detection kit. (Leica Biosystems, Bannockburn, IL) The protocol included in situ deparaffinization and high-pH epitope retrieval for 25 minutes, incubation with primary antibody for 30 minutes, polymer for 15 minutes, postpolymer for 15 minutes, and DAB as the chromogen for 10 minutes, followed by 5-minute hematoxylin counterstaining. MLH1, MSH2, MSH6, and PMS3 immunohistochemistry was performed to analyze mismatch repair (MMR) system status as previously reported. (27 (link)) For the detection of Epstein-Barr virus (EBV) infection, Bond™ Ready-to-Use ISH EBER Probe was used in Leica Bond-Max automation system according to the manufacturer instructions. (Leica Biosystems, Bannockburn, IL)
The stained sections were independently evaluated by two pathologists (SI and MM). PD-L1 immunoreactivity in placental trophoblasts and peripheral nerves were used as external and internal positive controls, respectively. PD-L1 has been reported to be expressed on not only tumor cells but also dendritic cells and TAIs, therefore, we evaluated PD-L1 expression in both neoplastic cells and TAIs with a detection cut-off of 5%.
Chi-square test or Fisher’s exact test were performed by SPSS software (IBM, Armonk, NY) to analyze the statistical correlation between PD-L1-expression and other tumor status such as MMR-deficiency, EBER-positivity, p16-, and ALK-expression.
Publication 2016
Antibodies azo rubin S CD30+ Anaplastic Large Cell Lymphoma CD274 protein, human Cells Choriocarcinoma Clone Cells Dendritic Cells Epitopes Epstein-Barr Virus Infections factor A Fetus Germ Cells Hematoxylin Immunoglobulins Immunohistochemistry Lung Cancer Melanocyte Mesenchyma Mismatch Repair MLH1 protein, human Monoclonal Antibodies MSH6 protein, human Neoplasms Neuroectoderm Operative Surgical Procedures Pathologists Peripheral Nerves Placenta Polymers Rabbits Squamous Epithelial Cells Technique, Dilution Tissues Trophoblast Turcot syndrome
During the period 2007 to 2009, four PAX5-positive anaplastic large cell lymphomas were identified from the hematopathology practice at Mayo Clinic, Rochester, Minnesota; 198 additional peripheral T-cell lymphomas from the years 1987 to 2009 identified from the Mayo Clinic archives were studied. All cases were classified based on 2008 WHO criteria.1
PAX5 immunohistochemistry was performed on paraffin embedded tissue sections by pretreating in 1mM EDTA buffer at pH 8.0 for 30 min at 97°C (PT Module; Lab Vision, Fremont, CA) and staining for PAX5 (1:200, clone 24, BD Bioscience) on a Dako (Carpinteria, CA) autostainer using the Advance detection system (Dako) with diaminobenzidine as the chromogen. Immunohistochemistry for other markers was performed as previously described35 (link) using antibodies shown in Table 1. Aside from CD30 and PAX5 (discussed below), immunostaining was scored as strong or weak, and designated as negative (-, no staining), focal (-/+, <10% of tumor cells), partial (+/-, 10-30% of tumor cells), or positive (+, >30% of tumor cells).
Polymerase chain reaction (PCR) for T-cell receptor (TCR) γ-chain and immunoglobulin gene rearrangements was performed as described previously.36 (link),37 (link) FISH for PAX5 was performed and scored as described previously using a homebrew breakapart probe.38 Briefly, DNA was isolated from bacterial artificial chromosome probes (ResGen - Invitrogen; Carlsbad, CA) spanning the PAX5 locus as shown in Fig. 3c. Probes were labeled with SpectrumOrange-dUTP or SpectrumGreen-dUTP by nick translation (Abbott Molecular, Des Plaines, IL) and hybridized to tissue sections. Cases with ≥4 fusion signals were considered to have extra copies of the PAX5 gene locus.
Additional peripheral T-cell lymphomas were evaluated by immunohistochemistry and/or FISH as indicated above on tissue microarrays constructed from paraffin blocks as previously described.39 (link) The study was approved by the Mayo Clinic Institutional Review Board and Biospecimens Committee.
Publication 2010
Antibodies azo rubin S Bacterial Artificial Chromosomes Buffers CD30+ Anaplastic Large Cell Lymphoma Cells Clone Cells Debility deoxyuridine triphosphate Edetic Acid Ethics Committees, Research Fishes Gene Rearrangement Genes, Immunoglobulin Genetic Loci Immunoglobulins Immunohistochemistry Microarray Analysis Neoplasms Paraffin Paraffin Embedding PAX5 protein, human Peripheral T-Cell Lymphoma T-Cell Receptor gamma-Chain Tissues Vision
The lymphoma cell lines Granta 519 (mantle cell lymphoma), Karpas 299, and SUDHL-1 (anaplastic large cell lymphoma) were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FCS), 2 mM glutamine, 100 μg/ml penicillin, and 100 μg/ml streptomycin (Life Technologies, Inc., Gaithersburg, MD, USA). The human embryonic kidney 293 T cells were grown in Dulbecco’s modified eagles medium with 10% FCS, 100 μg/ml penicillin, and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). Transfections were performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. Typically, cells growing on 60-mm Petri dishes were transfected with 0.5 μg reporter plasmid (pLC1 or pLS3) and 5.0 μg pSuper empty vector or pSuper with a specific siRNA sequence (shRNA vector). Cells were analyzed 48 or 72 h after transfection. To estimate the transfection efficiency, a green fluorescent protein (GFP)-coding plasmid (pEGFP, Clontech, Mountain View, CA, USA) was transfected in 293 T cells and the number of GFP-expressing cells was counted by fluorescence microscopy (Apotome, Zeiss MicroImaging GmbH, Göttingen, Germany). Transfection efficiencies for most experiments ranged from 70% to 99%.
Publication 2008
CD30+ Anaplastic Large Cell Lymphoma Cell Lines Cells Cloning Vectors Eagle Embryo Glutamine Green Fluorescent Proteins HEK293 Cells Homo sapiens Hyperostosis, Diffuse Idiopathic Skeletal Kidney lipofectamine 2000 Lymphoma Mantle-Cell Lymphoma Microscopy, Fluorescence Penicillins Plasmids RNA, Small Interfering Short Hairpin RNA Streptomycin Transfection

Most recents protocols related to «CD30+ Anaplastic Large Cell Lymphoma»

Data regarding demographics (age, BMI, height, weight, bra size, smoking status, comorbidities, parity), implant characteristics (volume, manufacturer, type, texture, shape), surgical technique (incision/approach, plane, placement, operative time), postoperative complications [dehiscence/exposure, hematoma, infection, implant rotation, implant rupture, seroma (late), asymmetry, capsular contracture, hypertrophic/wide scarring, nipple areolar complex asymmetry, ptosis, and excess skin laxity], reoperation rate, and follow-up times were recorded. Patients unhappy with their result due to personal preference (fear of breast implant-associated anaplastic large cell lymphoma, hyperplasia, hypoplasia, and/or pain) were also recorded. Late seroma was defined as occurring more than 12 months postoperatively.10 (link)–12 The complication category of “asymmetry” included implant displacement (bottoming out or laterally), double bubble, contour deformity, high riding implants, low inframmamary fold, and rippling. The frequency of complications was computed in regard to breasts affected.
Publication 2023
Areola Breast Capsule CD30+ Anaplastic Large Cell Lymphoma Congenital Abnormality Contracture Cutis Laxa Fear Hematoma Hyperplasia hypoplasia Implantations, Breast Infection Nipples Operative Surgical Procedures Pain Patients Postoperative Complications Prolapse Repeat Surgery Sadness Seroma
Informed written consent was obtained from all patients. Surgery was performed exclusively under general anesthesia, on an ambulatory basis. Surgery was performed in the United Kingdom at Hospital of St. John and St. Elizabeth, London Independent Hospital, London Welbeck Hospital and The Princess Grace Hospital, and in the United States at Greenwich Hospital, Norwalk Hospital, Norwalk Surgical Center, and Sasco Hill Surgery Center.
Sixteen patients (32 breasts) were reviewed over a 19-year period (Table 1). Six patients were treated within the last 2 years, reflecting the increasing demand for explantation surgery. Table 2 summarizes the indications for surgery. Figure 1 summarizes the treatment algorithm. The management of the capsule is based on intraoperative findings and not on preoperative evaluation because of the poor interobserver correlation of Baker grades.28 ,29 (link)The current indications for capsulectomy are Baker grade III and Baker IV capsular contracture and diagnosed BIA-ALCL.30 (link),31 (link) Not all Baker grade III or IV capsules require total capsulectomy. These patients should be evaluated for evidence of palpable calcifications, which may indicate a total capsulectomy. Ultimately, the decision to perform total capsulectomy should be discussed with the patient and may still be performed.32 (link)The decision to perform AFI is made preoperatively, predicated on thickness of lower pole breast parenchyma and patient request. Preference is to perform AFI simultaneously, enabling AFI into the pectoralis major muscle, inferior pedicle, and subglandular plane before closure, followed by subcutaneous AFI.11 (link) Patients with previous IMF incisions or prior mastopexy with unknown vascular supply to the nipple areolar complex (NAC) are managed with a bucket-handle pedicle (four patients). Each case is evaluated on its own merits.
Publication 2023
Areola Breast Capsule CD30+ Anaplastic Large Cell Lymphoma Contracture General Anesthesia Nipples Occlusal Plane Operative Surgical Procedures Patients Pectoralis Major Muscle Physiologic Calcification
The SWCNTs were functionalized using the Friedel–Crafts alkylation (FCA) process. The FCA process was carried out by mixing SWCNTs (0.4 g) and PVA (4 g) with a 40 mL DMSO solution in a 250 mL flask using a magnetic stirrer. The flask was then immersed in an oil bath for gradual heating to 90 °C in the presence of nitrogen. As the heating promotes the chemical process, a catalyst of aluminum chloride (ALCl 3 ) was added for grafting the PVA chains onto the surface of the SWCNTs. During the chemical process, the OH groups from PVA reacted with ALCl 3 and produced positive carbocations, (CH3 + ions: electrophiles), and negative ALCl 2 ions, respectively. The electrophiles were then attracted to the SWCNTs’ hexagonal ring due to the CNT’s surface delocalized electron (nucleophilic) sites, and thus attached the PVA chains onto the SWCNTs. After 20 h, the chemical reaction was aborted by adding 100 mL of methanol/hydrochloric acid mixture (volumetric ratio 1:1). The solution was then centrifuged at 3500 rpm for 15 min to precipitate the functionalized SWCNTs (f- SWCNTs). The f-SWCNTs were washed, filtered, and dried in a furnace for 3 h at 70 .
The Raman spectra were used to analyze the functionalization results of both pristine (p-SWCNTs) and functionalized SWCNTs (f-SWCNTs) and are shown in Figure 2i. The two peaks at the wavelengths of 1300–1400 cm 1 and 1500–1600 cm 1 were for the disorder (D band) and graphite band (G band), respectively. These bands represent two different vibrational modes of SWCNTs. The D band represents the crystal disorder, such as sidewall defects (pentagons or heptagons) or Sp3 carbon hybridization, and the G band was for the Sp2 carbon hybridization. The ratio of D band to G band ( ID/IG ) increases with the increasing disorder [19 ] and defines the structural changes of the SWCNTs wall due to functionalization [20 (link)]. In the current work, the ID/IG ratio was measured at 0.1025 and 0.1674 for p-SWCNTs and f-SWCNTs, respectively. The higher ratio of 0.1674 for f-SWCNTs was due to the carbocations attachment to the SWCNTs walls and the conversion of Sp2 to Sp3 hybridized carbons. This confirmed the PVA grafting to the SWCNTs wall during the FCA process [21 (link)].
Figure 2ii shows the FTIR spectrum for the range of 4000 to 500 cm 1 of both p-SWCNTs and f-SWCNTs. By analyzing the f-SWCNTs spectrum, the peak at 1028 cm 1 showed the C–O stretching, while the peak from 1100 to 1600 cm 1 confirmed the aromatic structures. The peaks corresponding to –CH and –OH bonds were obtained at 2900 cm 1 and 3200–3400 cm 1 , respectively. These peaks confirm that the PVA chains are attached to the surface of SWCNTs.
Full text: Click here
Publication 2023
Alkylation Aluminum Chloride Bath Carbon CD30+ Anaplastic Large Cell Lymphoma Chemical Processes Crossbreeding Electrons Graphite Hydrochloric acid Ions Methanol Nitrogen Spectroscopy, Fourier Transform Infrared Suby's G solution Sulfoxide, Dimethyl Vibration
We collected data from electronic patient files. Two different researchers (E.A.M.Z. and L.A.W.) collected data independently. Uncertainties were discussed together and, if necessary, with the other researchers (A.B., R.J.N.) to reach a consensus. Due to the retrospective design, no standard formats were used for the description of the investigated variables. For example, involvement of the body regions was scored based on the radiology reports. Sometimes, one of the investigators was not certain how to interpret the radiology reports. This was discussed with the colleagues, and if necessary, the radiology investigations were re-analyzed by the involved radiologist of our study.
Data were processed anonymously and encrypted.
We identified predicting factors for lymphoma based on an extensive search of the literature using PubMed, Medline, and Embase. We searched for studies using Medical Subject Heading terms including “lymphadenopathy”, “child”, “adolescent”, and “lymphoma”. An overview of potential predicting factors based on this search of the literature and their results are given in Table S1 [8 (link),31 (link),32 (link),33 (link),34 (link),35 (link),36 (link),37 (link),38 (link),46 ,47 (link),48 (link),49 (link),50 (link),51 (link),52 (link)]. We identified 39 potential predictors and included these in our univariate analyses: age, gender, presence of B-symptoms, 11 laboratory parameters including TARC, and several imaging findings. These variables and their definitions are listed in Table S2.
The body regions of the involved areas were scored individually. An overview of the separately scored anatomical body regions and an explanation is provided in Table S3.
We used pathology reports primarily for defining the diagnosis; 158 out of 182 patients underwent biopsy, including all cases of lymphoma. Twenty-four patients were diagnosed without a biopsy, but based on clinical, radiological, microbiological, and laboratory results (twenty infectious/reactive lymphadenopathy, one venous malformation, one lymphangioma, one branchiogenic cyst, and one dermoid cyst).
We categorized the patients into 12 groups according to their diagnosis. The malignant diagnoses in the study population included: cHL, NLPHL, ALCL, primary mediastinal large B-cell lymphoma (PMBCL), diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), T-LBL, B-cell lymphoblastic lymphoma (B-LBL), and other malignancies (Langerhans cell histiocytosis (LCH)). Furthermore, there were three groups with benign causes of lymphadenopathy: reactive or infectious lymphadenopathy, progressive transformation of germinal centers (PTGC), and other non-malignant causes.
For the identification of predictive factors, we divided the outcome into the benign group and the malignant group for univariate analysis. However, the malignant group contained nine different diagnoses, which differ significantly in incidence and clinical presentation. Therefore, we subdivided the group into five categories for multivariate analysis: cHL, NLPHL, NHL, other malignancies, and the benign group. In brief, we collected data from electronic patient files. We identified 39 potential predictors based on an extensive search of the literature. We used pathology reports for defining the diagnosis.
Full text: Click here
Publication 2023
Adolescent B-Cell Lymphomas Biopsy Body Regions Burkitt Lymphoma CD30+ Anaplastic Large Cell Lymphoma Child Congenital Abnormality Cyst Dermoid Cyst Diagnosis Differential Diagnosis Diffuse Large B-Cell Lymphoma Gender Histiocytosis, Langerhans-Cell Infection Lymphadenopathy Lymphangioma Lymphoma Malignant Neoplasms Mediastinum Outpatients Patients Radiologist Tests, Diagnostic Veins X-Rays, Diagnostic
None of the 1D RCTE models capture the 4 µm absorption feature seen in the data. We searched for several candidate gas species that could produce this feature if their abundances differ from the expected abundances from thermochemical equilibrium. The list of searched chemical species include C-bearing gases such as C2H2, CS, CS2, C2H6, C2H4, CH3, CH, C2, CH3Cl, CH3F, CN and CP. Various metal hydrides, bromides, flourides and chlorides such as LiH, AlH, FeH, CrH, BeH, TiH, CaH, HBr, LiCl, HCl, HF, AlCl, NaF and AlF were also searched as potential candidates to explain the feature. SO2, SO3, SO and SH are among the sulfur-based gases that were considered. Other species that were considered include gases such as PH3, H2S, HCN, N2O, GeH4, SiH4, SiO, AsH3, H2CO, H+3, OH+, KOH, Brα-H, AlO, CN, CP, CaF, H2O2, H3O+, HNO3, KF, MgO, PN, PO, PS, SiH, SiO2, SiS, TiO and VO.
Among all these gases, SO2 was the most promising candidate in terms of its spectral shape and chemical plausibility, although the expected chemical equilibrium abundance of SO2 is too low to produce the absorption signal seen in the data. However, previous work exploring photochemistry in exoplanetary atmospheres25 (link),26 (link) have shown that higher amounts of SO2 can be created in the upper atmospheres of irradiated planets through photochemical processes. Therefore, we postprocess the PICASO 3.0 and ScCHIMERA chemical equilibrium models with varying amounts of SO2 in a Bayesian framework to estimate the SO2 abundance required to explain the strength of the 4-µm feature. The required volume mixing ratio of SO2 was found to be roughly 10−5–10−6. Note that in obtaining this estimate we assumed that the SO2 volume mixing ratio does not vary with pressure for simplicity. In a photochemical scenario this assumption is probably not realistic, although the pressure range probed by SO2 is also limited. Whether photochemical models can produce this amount of SO2 in the atmospheric conditions of WASP-39b is a pressing question that the ERS team is now exploring (Welbanks et al. (in prep), Tsai et al. (submitted)). Whether this feature can be better explained by any other gaseous absorber is also at present under investigation by the ERS team.
Full text: Click here
Publication 2023
arsine Atmosphere Bromides CD30+ Anaplastic Large Cell Lymphoma Chlorides Gases Metals Peroxide, Hydrogen Photochemical Processes Pressure Sulfur Vision Wasps

Top products related to «CD30+ Anaplastic Large Cell Lymphoma»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in Germany
The SU-DHL-1 is a laboratory instrument designed for the detection and analysis of biomolecules. It utilizes spectroscopic techniques to measure the absorption and emission properties of samples. The core function of the SU-DHL-1 is to provide accurate and reliable data for research and analytical applications.
Sourced in United States, China, United Kingdom, Germany, France, Canada, Japan, Australia, Italy, Switzerland, Belgium, New Zealand, Austria, Netherlands, Israel, Sweden, Denmark, India, Ireland, Spain, Brazil, Norway, Argentina, Macao, Poland, Holy See (Vatican City State), Mexico, Hong Kong, Portugal, Cameroon
RPMI 1640 is a common cell culture medium used for the in vitro cultivation of a variety of cells, including human and animal cells. It provides a balanced salt solution and a source of essential nutrients and growth factors to support cell growth and proliferation.
Sourced in United States, China, Germany, United Kingdom, Japan, France, Canada, Australia, Italy, Switzerland, Belgium, New Zealand, Spain, Israel, Sweden, Denmark, Macao, Brazil, Ireland, India, Austria, Netherlands, Holy See (Vatican City State), Poland, Norway, Cameroon, Hong Kong, Morocco, Singapore, Thailand, Argentina, Taiwan, Province of China, Palestine, State of, Finland, Colombia, United Arab Emirates
RPMI 1640 medium is a commonly used cell culture medium developed at Roswell Park Memorial Institute. It is a balanced salt solution that provides essential nutrients, vitamins, and amino acids to support the growth and maintenance of a variety of cell types in vitro.
Sourced in Germany
Karpas-299 is a laboratory equipment used for the culture and analysis of microorganisms. It provides a controlled environment for the growth and observation of bacterial, fungal, and other microbial cultures. The core function of Karpas-299 is to facilitate the cultivation and study of microorganisms under standardized conditions.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in Germany
The SUP-M2 is a laboratory microorganism growth incubator designed for culturing a wide range of microorganisms, including bacteria, fungi, and algae. It provides a controlled environment with adjustable temperature and humidity settings to support optimal growth conditions for various microbial species.
Sourced in United States, Germany
The Karpas 299 is a laboratory equipment designed for the cultivation and maintenance of cell cultures. It provides a controlled environment for the growth and observation of various cell types, enabling researchers to study their characteristics and behaviors.
Sourced in United States, United Kingdom, Germany, France, Canada, Switzerland, Italy, Australia, Belgium, China, Japan, Austria, Spain, Brazil, Israel, Sweden, Ireland, Netherlands, Gabon, Macao, New Zealand, Holy See (Vatican City State), Portugal, Poland, Argentina, Colombia, India, Denmark, Singapore, Panama, Finland, Cameroon
L-glutamine is an amino acid that is commonly used as a dietary supplement and in cell culture media. It serves as a source of nitrogen and supports cellular growth and metabolism.
Sourced in Germany
The SR-786 is a laboratory equipment designed for centrifugation. It is a high-speed centrifuge that can be used to separate and isolate various components from liquid samples, such as cells, organelles, and macromolecules. The SR-786 is capable of reaching high rotational speeds, allowing for efficient separation of components based on their density and size.

More about "CD30+ Anaplastic Large Cell Lymphoma"

CD30-positive anaplastic large cell lymphoma (CD30+ ALCL) is a rare and aggressive form of non-Hodgkin lymphoma, a type of cancer that develops in the lymphatic system.
This cancer is characterized by the presence of the CD30 antigen on the surface of malignant T cells.
CD30+ ALCL is often challenging to manage, requiring a multimodal approach to treatment.
Researchers studying this complex disease can leverage the AI-driven platform PubCompare.ai to optimize their research efforts.
PubCompare.ai enables seamless comparisons of protocols from literature, preprints, and patents, helping researchers identify the most effective approaches to accelerate breakthroughs in CD30+ ALCL.
The malignant cells in CD30+ ALCL are typically derived from activated T cells and can be cultured in vitro using cell lines such as FBS, SU-DHL-1, Karpas-299, SUP-M2, and SR-786.
These cell lines are often maintained in RPMI 1640 medium supplemented with L-glutamine and penicillin/streptomycin to support their growth and survival.
By utilizing the advanced AI capabilities of PubCompare.ai, researchers can efficiently locate and compare protocols from the literature, preprints, and patents, ultimately identifying the most effective approaches to improve outcomes for patients with this rare and aggressive form of non-Hodgkin lymphoma.